aluates Reports

$ 0.0

Automative

Global Lysosomal Storage Diseases Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-34Q5936

Global Lysosomal Storage Diseases Market Insights and Forecast to 2028

BUY CHAPTERS

Global Lysosomal Storage Diseases Market Research Report 2025

Code: QYRE-Auto-34Q5936

Report

September 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Actelion Pharmaceuticals

BioMarin

Genzyme

Takeda

Alexion Pharmaceuticals

Amicus Therapeutics

Chiesi Farmaceutici

Greenovation Biotech And FGK Clinical Research

Horizon Pharma

Leadiant Biosciences

Mylan NV

Lysosomal Storage Diseases Market Size

The global market for Lysosomal Storage Diseases was valued at US$ 8194 million in the year 2024 and is projected to reach a revised size of US$ 11400 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Lysosomal Storage Diseases Market

Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.

According to the report, one driver in the market is unmet medical needs.

This report aims to provide a comprehensive presentation of the global market for Lysosomal Storage Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysosomal Storage Diseases.

The Lysosomal Storage Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lysosomal Storage Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lysosomal Storage Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lysosomal Storage Diseases Market Report

Report Metric	Details
Report Name	Lysosomal Storage Diseases Market
Accounted market size in year	US$ 8194 million
Forecasted market size in 2031	US$ 11400 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Enzyme Replacement Therapy Substrate Reduction Therapy Cystine Depleting Agents
Segment by Application	Hospitals Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research, Horizon Pharma, Leadiant Biosciences, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lysosomal Storage Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lysosomal Storage Diseases Market growing?

Ans: The Lysosomal Storage Diseases Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Lysosomal Storage Diseases Market size in 2031?

Ans: The Lysosomal Storage Diseases Market size in 2031 will be US$ 11400 million.

Who are the main players in the Lysosomal Storage Diseases Market report?

Ans: The main players in the Lysosomal Storage Diseases Market are Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research, Horizon Pharma, Leadiant Biosciences, Mylan

What are the Application segmentation covered in the Lysosomal Storage Diseases Market report?

Ans: The Applications covered in the Lysosomal Storage Diseases Market report are Hospitals, Ambulatory Surgical Centers

What are the Type segmentation covered in the Lysosomal Storage Diseases Market report?

Ans: The Types covered in the Lysosomal Storage Diseases Market report are Enzyme Replacement Therapy, Substrate Reduction Therapy, Cystine Depleting Agents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Enzyme Replacement Therapy

1.2.3 Substrate Reduction Therapy

1.2.4 Cystine Depleting Agents

1.3 Market by Application

1.3.1 Global Lysosomal Storage Diseases Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lysosomal Storage Diseases Market Perspective (2020-2031)

2.2 Global Lysosomal Storage Diseases Growth Trends by Region

2.2.1 Global Lysosomal Storage Diseases Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lysosomal Storage Diseases Historic Market Size by Region (2020-2025)

2.2.3 Lysosomal Storage Diseases Forecasted Market Size by Region (2026-2031)

2.3 Lysosomal Storage Diseases Market Dynamics

2.3.1 Lysosomal Storage Diseases Industry Trends

2.3.2 Lysosomal Storage Diseases Market Drivers

2.3.3 Lysosomal Storage Diseases Market Challenges

2.3.4 Lysosomal Storage Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lysosomal Storage Diseases Players by Revenue

3.1.1 Global Top Lysosomal Storage Diseases Players by Revenue (2020-2025)

3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Players (2020-2025)

3.2 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lysosomal Storage Diseases Revenue

3.4 Global Lysosomal Storage Diseases Market Concentration Ratio

3.4.1 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Revenue in 2024

3.5 Global Key Players of Lysosomal Storage Diseases Head office and Area Served

3.6 Global Key Players of Lysosomal Storage Diseases, Product and Application

3.7 Global Key Players of Lysosomal Storage Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lysosomal Storage Diseases Breakdown Data by Type

4.1 Global Lysosomal Storage Diseases Historic Market Size by Type (2020-2025)

4.2 Global Lysosomal Storage Diseases Forecasted Market Size by Type (2026-2031)

5 Lysosomal Storage Diseases Breakdown Data by Application

5.1 Global Lysosomal Storage Diseases Historic Market Size by Application (2020-2025)

5.2 Global Lysosomal Storage Diseases Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lysosomal Storage Diseases Market Size (2020-2031)

6.2 North America Lysosomal Storage Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lysosomal Storage Diseases Market Size by Country (2020-2025)

6.4 North America Lysosomal Storage Diseases Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lysosomal Storage Diseases Market Size (2020-2031)

7.2 Europe Lysosomal Storage Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lysosomal Storage Diseases Market Size by Country (2020-2025)

7.4 Europe Lysosomal Storage Diseases Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lysosomal Storage Diseases Market Size (2020-2031)

8.2 Asia-Pacific Lysosomal Storage Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2020-2025)

8.4 Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lysosomal Storage Diseases Market Size (2020-2031)

9.2 Latin America Lysosomal Storage Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lysosomal Storage Diseases Market Size by Country (2020-2025)

9.4 Latin America Lysosomal Storage Diseases Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lysosomal Storage Diseases Market Size (2020-2031)

10.2 Middle East & Africa Lysosomal Storage Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2020-2025)

10.4 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Actelion Pharmaceuticals

11.1.1 Actelion Pharmaceuticals Company Details

11.1.2 Actelion Pharmaceuticals Business Overview

11.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction

11.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.1.5 Actelion Pharmaceuticals Recent Development

11.2 BioMarin

11.2.1 BioMarin Company Details

11.2.2 BioMarin Business Overview

11.2.3 BioMarin Lysosomal Storage Diseases Introduction

11.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.2.5 BioMarin Recent Development

11.3 Genzyme

11.3.1 Genzyme Company Details

11.3.2 Genzyme Business Overview

11.3.3 Genzyme Lysosomal Storage Diseases Introduction

11.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.3.5 Genzyme Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Lysosomal Storage Diseases Introduction

11.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Alexion Pharmaceuticals

11.5.1 Alexion Pharmaceuticals Company Details

11.5.2 Alexion Pharmaceuticals Business Overview

11.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction

11.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.5.5 Alexion Pharmaceuticals Recent Development

11.6 Amicus Therapeutics

11.6.1 Amicus Therapeutics Company Details

11.6.2 Amicus Therapeutics Business Overview

11.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction

11.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.6.5 Amicus Therapeutics Recent Development

11.7 Chiesi Farmaceutici

11.7.1 Chiesi Farmaceutici Company Details

11.7.2 Chiesi Farmaceutici Business Overview

11.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction

11.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.7.5 Chiesi Farmaceutici Recent Development

11.8 Greenovation Biotech And FGK Clinical Research

11.8.1 Greenovation Biotech And FGK Clinical Research Company Details

11.8.2 Greenovation Biotech And FGK Clinical Research Business Overview

11.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction

11.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.8.5 Greenovation Biotech And FGK Clinical Research Recent Development

11.9 Horizon Pharma

11.9.1 Horizon Pharma Company Details

11.9.2 Horizon Pharma Business Overview

11.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction

11.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.9.5 Horizon Pharma Recent Development

11.10 Leadiant Biosciences

11.10.1 Leadiant Biosciences Company Details

11.10.2 Leadiant Biosciences Business Overview

11.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction

11.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.10.5 Leadiant Biosciences Recent Development

11.11 Mylan

11.11.1 Mylan Company Details

11.11.2 Mylan Business Overview

11.11.3 Mylan Lysosomal Storage Diseases Introduction

11.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2020-2025)

11.11.5 Mylan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Actelion Pharmaceuticals

BioMarin

Genzyme

Takeda

Alexion Pharmaceuticals

Amicus Therapeutics

Chiesi Farmaceutici

Greenovation Biotech And FGK Clinical Research

Horizon Pharma

Leadiant Biosciences

Mylan NV

List of Tables

Table 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Enzyme Replacement Therapy

Table 3. Key Players of Substrate Reduction Therapy

Table 4. Key Players of Cystine Depleting Agents

Table 5. Global Lysosomal Storage Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lysosomal Storage Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Lysosomal Storage Diseases Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Lysosomal Storage Diseases Market Share by Region (2020-2025)

Table 9. Global Lysosomal Storage Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Lysosomal Storage Diseases Market Share by Region (2026-2031)

Table 11. Lysosomal Storage Diseases Market Trends

Table 12. Lysosomal Storage Diseases Market Drivers

Table 13. Lysosomal Storage Diseases Market Challenges

Table 14. Lysosomal Storage Diseases Market Restraints

Table 15. Global Lysosomal Storage Diseases Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Lysosomal Storage Diseases Market Share by Players (2020-2025)

Table 17. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2024)

Table 18. Ranking of Global Top Lysosomal Storage Diseases Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Lysosomal Storage Diseases, Headquarters and Area Served

Table 21. Global Key Players of Lysosomal Storage Diseases, Product and Application

Table 22. Global Key Players of Lysosomal Storage Diseases, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Lysosomal Storage Diseases Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Lysosomal Storage Diseases Revenue Market Share by Type (2020-2025)

Table 26. Global Lysosomal Storage Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Lysosomal Storage Diseases Revenue Market Share by Type (2026-2031)

Table 28. Global Lysosomal Storage Diseases Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Lysosomal Storage Diseases Revenue Market Share by Application (2020-2025)

Table 30. Global Lysosomal Storage Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Lysosomal Storage Diseases Revenue Market Share by Application (2026-2031)

Table 32. North America Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Lysosomal Storage Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Lysosomal Storage Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Lysosomal Storage Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Lysosomal Storage Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Lysosomal Storage Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Lysosomal Storage Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Lysosomal Storage Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 47. Actelion Pharmaceuticals Company Details

Table 48. Actelion Pharmaceuticals Business Overview

Table 49. Actelion Pharmaceuticals Lysosomal Storage Diseases Product

Table 50. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 51. Actelion Pharmaceuticals Recent Development

Table 52. BioMarin Company Details

Table 53. BioMarin Business Overview

Table 54. BioMarin Lysosomal Storage Diseases Product

Table 55. BioMarin Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 56. BioMarin Recent Development

Table 57. Genzyme Company Details

Table 58. Genzyme Business Overview

Table 59. Genzyme Lysosomal Storage Diseases Product

Table 60. Genzyme Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 61. Genzyme Recent Development

Table 62. Takeda Company Details

Table 63. Takeda Business Overview

Table 64. Takeda Lysosomal Storage Diseases Product

Table 65. Takeda Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 66. Takeda Recent Development

Table 67. Alexion Pharmaceuticals Company Details

Table 68. Alexion Pharmaceuticals Business Overview

Table 69. Alexion Pharmaceuticals Lysosomal Storage Diseases Product

Table 70. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 71. Alexion Pharmaceuticals Recent Development

Table 72. Amicus Therapeutics Company Details

Table 73. Amicus Therapeutics Business Overview

Table 74. Amicus Therapeutics Lysosomal Storage Diseases Product

Table 75. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 76. Amicus Therapeutics Recent Development

Table 77. Chiesi Farmaceutici Company Details

Table 78. Chiesi Farmaceutici Business Overview

Table 79. Chiesi Farmaceutici Lysosomal Storage Diseases Product

Table 80. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 81. Chiesi Farmaceutici Recent Development

Table 82. Greenovation Biotech And FGK Clinical Research Company Details

Table 83. Greenovation Biotech And FGK Clinical Research Business Overview

Table 84. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product

Table 85. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 86. Greenovation Biotech And FGK Clinical Research Recent Development

Table 87. Horizon Pharma Company Details

Table 88. Horizon Pharma Business Overview

Table 89. Horizon Pharma Lysosomal Storage Diseases Product

Table 90. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 91. Horizon Pharma Recent Development

Table 92. Leadiant Biosciences Company Details

Table 93. Leadiant Biosciences Business Overview

Table 94. Leadiant Biosciences Lysosomal Storage Diseases Product

Table 95. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 96. Leadiant Biosciences Recent Development

Table 97. Mylan Company Details

Table 98. Mylan Business Overview

Table 99. Mylan Lysosomal Storage Diseases Product

Table 100. Mylan Revenue in Lysosomal Storage Diseases Business (2020-2025) & (US$ Million)

Table 101. Mylan Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Lysosomal Storage Diseases Picture

Figure 2. Global Lysosomal Storage Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lysosomal Storage Diseases Market Share by Type: 2024 VS 2031

Figure 4. Enzyme Replacement Therapy Features

Figure 5. Substrate Reduction Therapy Features

Figure 6. Cystine Depleting Agents Features

Figure 7. Global Lysosomal Storage Diseases Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Lysosomal Storage Diseases Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Ambulatory Surgical Centers Case Studies

Figure 11. Lysosomal Storage Diseases Report Years Considered

Figure 12. Global Lysosomal Storage Diseases Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lysosomal Storage Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lysosomal Storage Diseases Market Share by Region: 2024 VS 2031

Figure 15. Global Lysosomal Storage Diseases Market Share by Players in 2024

Figure 16. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2024

Figure 18. North America Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lysosomal Storage Diseases Market Share by Country (2020-2031)

Figure 20. United States Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lysosomal Storage Diseases Market Share by Country (2020-2031)

Figure 24. Germany Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lysosomal Storage Diseases Market Share by Region (2020-2031)

Figure 32. China Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lysosomal Storage Diseases Market Share by Country (2020-2031)

Figure 40. Mexico Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lysosomal Storage Diseases Market Share by Country (2020-2031)

Figure 44. Turkey Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Lysosomal Storage Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 48. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 49. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 50. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 51. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 52. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 53. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 54. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 55. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 56. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 57. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lysosomal Storage Disease Treatment Drugs Market Research Report 2024

Global Lysosomal Storage Disease Treatment Market Research Report 2024

Global Sphingolipidoses Treatment Market Research Report 2025

Global Lysosomal Storage Disorder Drugs Market Research Report 2024

Mucopolysaccharidosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mucopolysaccharidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fabry Disease Treatment Market Insights Forecast to 2030

Global Krabbe Disease Treatment Market Research Report 2024

Global Mucopolysaccharidosis MPS Treatment Market Research Report 2024

Global Gaucher Disease GD Drugs Market Insights Forecast to 2030

Gaucher Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lysosomal Acid Lipase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gaucher Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pompe Disease Treatment Market Research Report 2024

Global Lysosome Extraction Kit Market Research Report 2024

Global Glycogen Storage Disorders GSD Clinical Trials Market Research Report 2024

Alpha Mannosidosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lennox Gastaut Syndrome Treatment Market Insights Forecast to 2030

Global Gaucher s Disease Oral Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24R5886

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Diseases Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34Q5936

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Acute Intermittent Porphyria Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6U7336

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Phenylketonuria Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12R6229

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Lysosomal Storage Diseases Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-34Q5936

Global Lysosomal Storage Diseases Market Research Report 2025

FEATURED COMPANIES

Lysosomal Storage Diseases Market Size

Lysosomal Storage Diseases Market

Scope of Lysosomal Storage Diseases Market Report

Chapter Outline

FAQ for this report

How fast is Lysosomal Storage Diseases Market growing?

What is the Lysosomal Storage Diseases Market size in 2031?

Who are the main players in the Lysosomal Storage Diseases Market report?

What are the Application segmentation covered in the Lysosomal Storage Diseases Market report?

What are the Type segmentation covered in the Lysosomal Storage Diseases Market report?

FEATURED COMPANIES

RELATED REPORTS